Athira Pharma, Inc.
Industry: Life Sciences ・ $ATHA on Nasdaq
Insider Sale
+$14,026
-2.85%
Shares
Shares Volume: 4,820 Shares
Average Share Price: $2.91
INSIDER
Litton Mark James
CEO (Director)
reported on Feb 16 2024
traded on Jan 4 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 164,086 |
| PURCHASES/SALES 1Y | 0 / 2 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $14,026.2 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 5 / 9 |
| P/S VALUE RATIO | 24.931 |
| AVERAGE SALE VALUE | $7,797.51 |
| COMPANY PREVIOUS TRADES |